There are a number of areas where pharmacy benefit managers can help support employers with the high-cost of specialty pharmacy drugs, but so far they have only been doing a good job in some priority areas, said Bruce Sherman, MD, FCCP, FACOEM.
There are a number of areas where pharmacy benefit managers (PBMs) can help support employers with the high-cost of specialty pharmacy drugs, but so far they have only been doing a good job in some priority areas, said Bruce Sherman, MD, FCCP, FACOEM, of Case Western Reserve, University School of Medicine and medical director of Population Health and Management Exchange Solutions with Buck Consultants at Xerox.
Transcript (slightly modified)
How can pharmacy benefit managers help employers get a grasp on specialty drug spending?
The issue for employers is that there is an ever-growing and expansive pipeline of specialty pharmacy drugs, and as such employers wil certainly benefit from support from the PBMs to control costs. To that end, the PBMs can certainly help by ensuring that they take as supportive of a role as they can in terms of ensuring that the right patient gets the right drug, at the right time, at the right cost, and in the right setting.
Those are really the primary group of targets. To this point, PBMs have been doing a reasonable job in some of those areas, but not all.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
STEER Data Open Door to SMA Gene Therapy for Wider Age Range of Children
March 19th 2025Delivery of onasemnogene abeparvovec into the intrathecal space was safe and effective for children with spinal muscular atrophy (SMA) aged 2 to 17 years, who had previously been shut out of receiving gene therapy.
Read More